Literature DB >> 8483642

Beta-endorphins and mood states during resistance exercise.

R W McGowan1, E F Pierce, N Eastman, H L Tripathi, T Dewey, K Olson.   

Abstract

Research examining the relationship between beta-endorphin immunoreactivity and affect has resulted in equivocal findings. To examine this relationship further, 10 male and 10 female college-age students participated in a controlled free-weight exercise session. Blood plasma samples were procured both prior to and following the exercise bout and beta-endorphin levels were determined by immunoassay. Analysis indicated that plasma beta-endorphin levels following exercise were significantly decreased from pre-exercise levels. Pearson correlations showed no significant relationship between pre- or postexercise plasma beta-endorphins and either total mood disturbance or Profile of Mood States subscores. The data support previous failure of resistance exercise to produce an increase in beta-endorphin immunoreactivity as well as the lack of a significant relationship between affect and the beta-endorphin response to exercise.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483642     DOI: 10.2466/pms.1993.76.2.376

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  3 in total

Review 1.  Trauma-induced systemic inflammatory response versus exercise-induced immunomodulatory effects.

Authors:  Elvira Fehrenbach; Marion E Schneider
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

2.  Resistance exercise decreases beta-endorphin immunoreactivity.

Authors:  E F Pierce; N W Eastman; R W McGowan; H Tripathi; W L Dewey; K G Olson
Journal:  Br J Sports Med       Date:  1994-09       Impact factor: 13.800

3.  Prognostic value of exercise capacity among patients with treated depression: The Henry Ford Exercise Testing (FIT) Project.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Sherif Sakr; Michael J Blaha; Clinton A Brawner; Jonathan K Ehrman; Steven J Keteyian; Mouaz H Al-Mallah
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.